Immunogenicity of varicella-zoster virus glycoprotein E formulated with lipid nanoparticles and nucleic immunostimulators in mice

16Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

Theoretically, the subunit herpes zoster vaccine Shingrix™ could be used as a varicella vaccine that avoids the risk of developing shingles from vaccination, but bedside mixing strategies and the limited supply of the adjuvant component QS21 have made its application economically impracticable. With lipid nanoparticles (LNPs) that were approved by the FDA as vectors for severe acute respiratory syndrome coronavirus 2 vaccines, we designed a series of vaccines efficiently encapsulated with varicella-zoster virus glycoprotein E (VZV-gE) and nucleic acids including polyinosinic-polycytidylic acid (Poly I:C) and the natural phosphodiester CpG oligodeoxynucleotide (CpG ODN), which was approved by the FDA as an immunostimulator in a hepatitis B vaccine. Preclinical trial in mice showed that these LNP vaccines could induce VZV-gE IgG titers more than 16 times those induced by an alum adjuvant, and immunized serum could block in vitro infection completely at a dilution of 1:80, which indicated potential as a varicella vaccine. The magnitude of the cell-mediated immunity induced was generally more than 10 times that induced by the alum adjuvant, indicating potential as a zoster vaccine. These results showed that immunostimulatory nucleic acids together with LNPs have promise as safe and economical varicella and zoster vaccine candidates.

References Powered by Scopus

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

10530Citations
N/AReaders
Get full text

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

2183Citations
N/AReaders
Get full text

Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults

1117Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Microfluidics for nano-drug delivery systems: From fundamentals to industrialization

43Citations
N/AReaders
Get full text

An established th2-oriented response to an alum-adjuvanted sars-cov-2 subunit vaccine is not reversible by sequential immunization with nucleic acid-adjuvanted th1-oriented subunit vaccines

12Citations
N/AReaders
Get full text

LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix™ in VZV-primed mice

10Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cao, H., Wang, Y., Luan, N., & Liu, C. (2021). Immunogenicity of varicella-zoster virus glycoprotein E formulated with lipid nanoparticles and nucleic immunostimulators in mice. Vaccines, 9(4). https://doi.org/10.3390/vaccines9040310

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

69%

Researcher 4

25%

Professor / Associate Prof. 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

53%

Biochemistry, Genetics and Molecular Bi... 3

20%

Immunology and Microbiology 3

20%

Materials Science 1

7%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
Social Media
Shares, Likes & Comments: 2

Save time finding and organizing research with Mendeley

Sign up for free